Pattern of Proton Pump Inhibitor Calls to Texas Poison Centers, 1998–2004

REFERENCES

• Andersson , T. 1996 . Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole . Clin. Pharmacokinet. , 31 : 9 – 28 .
   PubMed Web of Science ®Google Scholar
• Besancon , M. , Simon , A. , Sachs , G. and Shin , J. M. 1997 . Sites of reaction of the gastric H, K-ATPase with extracytoplasmic thiol reagents . J. Biol. Chem. , 272 : 22438 – 22446 .
   PubMed Web of Science ®Google Scholar
• Blankenhorn , K. and Lipson , D. 2002 . Business watch: 2001 in review: Despite economic challenges, pharmaceutical industry still maintains steady growth . Med. Mark. Med. , 37 : 46 – 62 .
   Google Scholar
• Byrne , M. F. and Murray , F. E. 1999 . Formulary management of proton pump inhibitors . Pharmacoeconomics. , 16 : 225 – 246 .
   PubMed Web of Science ®Google Scholar
• Feret , B. , Quercia , R. A. and Cappa , J. 1999 . Rabeprazole: A proton pump inhibitor for the treatment of acid-related disorders . Formulary , 34 : 313 – 323 .
   Google Scholar
• Fitton , A. and Wiseman , L. 1996 . Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders . Drugs , 51 : 460 – 482 .
   PubMed Web of Science ®Google Scholar
• Freston , J. W. 1997 . Long-term acid control and proton pump inhibitors: Interactions and safety issues in perspective . Am. J. Gastroenterol. , 92 : 51S – 57S .
   Google Scholar
• Garnett , W. R. 1998 . Considerations for long-term use of proton-pump inhibitors . Am. J. Health Syst. Pharm. , 55 : 2268 – 2279 .
   PubMed Web of Science ®Google Scholar
• Horn , J. 2000 . The proton-pump inhibitors: Similarities and differences . Clin. Ther. , 22 : 266 – 280 .
   PubMed Web of Science ®Google Scholar
• Kromer , W. , Kruger , U. , Huber , R. , Hartmann , M. and Steinijans , V. W. 1998 . Differences in pH-dependent activation rates of substituted benzimidazoles and biological in vitro correlates . Pharmacology. , 56 : 57 – 70 .
   PubMed Web of Science ®Google Scholar
• Litalien , C. , Theoret , Y. and Faure , C. 2005 . Pharmacokinetics of proton pump inhibitors in children . Clin. Pharmacokinet. , 44 : 441 – 466 .
   PubMed Web of Science ®Google Scholar
• Litovitz , T. L. , Klein-Schwartz , W. , Rodgers , G. C. , Cobaugh , D. J. , Youniss , J. , Omslaer , J. C. , May , M. E. , Woolf , A. D. and Benson , B. E. 2002 . 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System . Am. J. Emerg. Med. , 20 : 391 – 452 .
   PubMed Web of Science ®Google Scholar
• Richardson , P. , Hawkey , C. J. and Stack , W. A. 1998 . Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders . Drugs , 56 : 307 – 335 .
   PubMed Web of Science ®Google Scholar
• Robinson , M. and Shaw , K. 2002 . Proton pump inhibitor attitudes and usage: A patient survey . Pharmacy Therapeut. , 27 : 202 – 206 .
   Google Scholar
• Robinson , M. and Horn , J. 2003 . Clinical pharmacology of proton pump inhibitors: What the practising physician needs to know . Drugs , 63 : 2739 – 2754 .
   PubMed Web of Science ®Google Scholar
• Watson , W. A. , Litovitz , T. L. , Rodgers , G. C. , Klein-Schwartz , W. , Youniss , J. , Rose , S. R. , Borys , D. and May , M. E. 2003 . 2002 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System . Am. J. Emerg. Med. , 21 : 353 – 421 .
   PubMed Web of Science ®Google Scholar
• Watson , W. A. , Litovitz , T. L. , Klein-Schwartz , W. , Rodgers , G. C. , Youniss , J. , Reid , N. , Rouse , W. G. , Rembert , R. S. and Borys , D. 2004 . 2003 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System . Am. J. Emerg. Med. , 22 : 335 – 404 .
   PubMed Web of Science ®Google Scholar
• Watson , W. A. , Litovitz , T. L. , Rodgers , G. C. , Klein-Schwartz , W. , Reid , N. , Youniss , J. , Flanagan , A. and Wruk , K. M. 2005 . 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System . Am. J. Emerg. Med. , 23 : 589 – 666 .
   PubMed Web of Science ®Google Scholar
• Welage , L. S. and Berardi , R. R. 2000 . Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases . J. Am. Pharm. Assoc. (Wash.) , 40 : 52 – 62 .
   PubMedGoogle Scholar
• Zachry , W. M. , Shepherd , M. D. , Hinich , M. J. , Wilson , J. P. , Brown , C. M. and Lawson , K. A. 2002 . Relationship between direct-to-consumer advertising and physician diagnosing and prescribing . Am. J. Health Syst. Pharm. , 59 : 42 – 49 .
   PubMed Web of Science ®Google Scholar